Moleculin Biotech
Price & Volume
Stats
See moreOpen | $0.35 |
Previous Close | $0.36 |
Day Range | $0.35-$0.36 |
52W Range | $0.25-$3.10 |
Market Cap | $22.4M |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.74 |
News
See moreYahoo Finance • 12 days ago
Moleculin Reports 60% of First 45 Subjects in Pivotal “MIRACLE” Phase 3 AML Trial Consented
Yahoo Finance • 13 days ago
Moleculin Announces Grant Funded Research Evaluating Annamycin for the Treatment of Pancreatic Cancer at UNC-Chapel Hill
Yahoo Finance • 26 days ago
Moleculin to Highlight its Ongoing Phase 3 Acute Myeloid Leukemia “MIRACLE” Clinical Trial at the 14th Annual Acute Leukemia Meeting
Yahoo Finance • 27 days ago
Moleculin Expands Global IP Portfolio with New Australian Patent for Annamycin
About
CEO | Mr. Walter V. Klemp |
CFO | Mr. Jonathan P. Foster CPA |
Address | 5300 Memorial Drive, Houston, TX, United States, 77007 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 17 |
